Our work is entirely funded by private donations – we receive no money from government. Your money will help us continue funding research into vitiligo and supporting people affected by the condition.
World Vitiligo Map
Your guide to the vitiligo community worldwide. Use the selector to filter by patient support groups, specialists, research centers, clinical trial locations, or World Vitiligo Day events.
Directory Information & Disclaimer
This free public directory gathers information from public sources to help connect our global community. Medical professionals and organizations listed are independent and not affiliated with or endorsed by the Vitiligo Research Foundation (VRF), and no fees are accepted for listings.
Because clinics, support groups, and specialists move or update their services over time, some information may occasionally become outdated. As a result, VRF cannot guarantee the complete accuracy or usefulness of listed third-party resources.
Help Us Keep the Map Accurate
Do you need to add a listing, update outdated details, or request a removal? Please reach out to us using the feedback form on our Contact Us page.
Search Map
67 records found for “NCT07108283” · show all
- A Study of Zasocitinib in Adults With Nonsegmental Vitiligo
Phase: PHASE2
Intervention: Drug: Zasocitinib; Other: Placebo
Status: Open now
Organizer: Takeda
Trial page: https://vrfoundation.org/trials/zasocitinib-tablets-for-nonsegmental-vitiligo-218206f6-e272-4a6a-85d8-caffeadb781aTokyo Medical University Hospital, Tokyo, TAkyA, 160-0023, Japan
+1-877-825-3327
- A Study of Zasocitinib in Adults With Nonsegmental Vitiligo
Phase: PHASE2
Intervention: Drug: Zasocitinib; Other: Placebo
Status: Open now
Organizer: Takeda
Trial page: https://vrfoundation.org/trials/zasocitinib-tablets-for-nonsegmental-vitiligo-218206f6-e272-4a6a-85d8-caffeadb781aCRI Centro Regiomontano de Investigation SC, Monterrey, New Leon, 64060, Mexico
+1-877-825-3327
- A Study of Zasocitinib in Adults With Nonsegmental Vitiligo
Phase: PHASE2
Intervention: Drug: Zasocitinib; Other: Placebo
Status: Open now
Organizer: Takeda
Trial page: https://vrfoundation.org/trials/zasocitinib-tablets-for-nonsegmental-vitiligo-218206f6-e272-4a6a-85d8-caffeadb781aClinica de Enfermedades Cronicas y de Procedimientos Especiales, Morelia, Predeterminado, 58249, Mexico
+1-877-825-3327
- A Study of Zasocitinib in Adults With Nonsegmental Vitiligo
Phase: PHASE2
Intervention: Drug: Zasocitinib; Other: Placebo
Status: Open now
Organizer: Takeda
Trial page: https://vrfoundation.org/trials/zasocitinib-tablets-for-nonsegmental-vitiligo-218206f6-e272-4a6a-85d8-caffeadb781aGyncentrum Sp. z o.o., Katowice, 40-600, Poland
+1-877-825-3327
- A Study of Zasocitinib in Adults With Nonsegmental Vitiligo
Phase: PHASE2
Intervention: Drug: Zasocitinib; Other: Placebo
Status: Open now
Organizer: Takeda
Trial page: https://vrfoundation.org/trials/zasocitinib-tablets-for-nonsegmental-vitiligo-218206f6-e272-4a6a-85d8-caffeadb781aHospital Universitario de Gran Canaria Doctor Negrin, Las Palmas de Gran Canaria, Las Palmas, 35010, Spain
+1-877-825-3327
- A Study of Zasocitinib in Adults With Nonsegmental Vitiligo
Phase: PHASE2
Intervention: Drug: Zasocitinib; Other: Placebo
Status: Open now
Organizer: Takeda
Trial page: https://vrfoundation.org/trials/zasocitinib-tablets-for-nonsegmental-vitiligo-218206f6-e272-4a6a-85d8-caffeadb781aHospital Universitario Reina Sofia, Córdoba, 14004, Spain
+1-877-825-3327
- A Study of Zasocitinib in Adults With Nonsegmental Vitiligo
Phase: PHASE2
Intervention: Drug: Zasocitinib; Other: Placebo
Status: Open now
Organizer: Takeda
Trial page: https://vrfoundation.org/trials/zasocitinib-tablets-for-nonsegmental-vitiligo-218206f6-e272-4a6a-85d8-caffeadb781aHospital Universitario La Paz (HULP), Madrid, 28034, Spain
+1-877-825-3327
FAQOther Questions
- How Vitiligo Changes with Age?
Vitiligo, a condition characterized by the loss of skin pigmentation, can affect individuals at any stage of life. While it often appears before the age of 20, its progression a...
- Which skin conditions can be mistaken for vitiligo?
Vitiligo is a common skin condition with characteristic milky white patches of irregular shape. However, several other skin conditions exhibit similar symptoms that can lead to ...
- Does vitiligo increase the risk of skin cancer?
No, it does not. Despite common misconceptions, people with vitiligo are actually at a lower risk of developing skin cancer—including both nonmelanoma skin cancer (NMSC) and mal...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.
Copyright (C) Bodolóczki JúliaBy taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.